Matches in SemOpenAlex for { <https://semopenalex.org/work/W3006077914> ?p ?o ?g. }
- W3006077914 endingPage "570" @default.
- W3006077914 startingPage "563" @default.
- W3006077914 abstract "Currently, there are no clinically approved treatments for ischemia-reperfusion injury after lung transplantation. Pre-clinical animal models have demonstrated a promising efficacy of adenosine 2A receptor (A2AR) agonists as a treatment option for reducing ischemia-reperfusion injury. The purpose of this human study, is to conduct a Phase I clinical trial for evaluating the safety of continuous infusion of an A2AR agonist in lung transplant recipients.An adaptive, two-stage continual reassessment trial was designed to evaluate the safety of regadenoson (A2AR agonist) in the setting of lung transplantation. Continuous infusion of regadenoson was administered to lung transplant recipients that was started at the time of skin incision. Adverse events and dose-limiting toxicities, as pre-determined by a study team and assessed by a clinical team and an independent safety monitor, were the primary end-points for safety in this trial.Between January 2018 and March 2019, 14 recipients were enrolled in the trial. Of these, 10 received the maximum infused dose of 1.44 µg/kg/min for 12 hours. No dose-limiting toxicities were observed. The steady-state plasma regadenoson levels sampled before the reperfusion of the first lung were 0.98 ± 0.46 ng/ml. There were no mortalities within 30 days.Regadenoson, an A2AR agonist, can be safely infused in the setting of lung transplantation with no dose-limiting toxicities or drug-related mortality. Although not powered for the evaluation of secondary end-points, the results of this trial and the outcome of pre-clinical studies warrant further investigation with a Phase II randomized controlled trial." @default.
- W3006077914 created "2020-02-24" @default.
- W3006077914 creator A5006411878 @default.
- W3006077914 creator A5013241838 @default.
- W3006077914 creator A5021842242 @default.
- W3006077914 creator A5025854985 @default.
- W3006077914 creator A5028488821 @default.
- W3006077914 creator A5029401500 @default.
- W3006077914 creator A5032571354 @default.
- W3006077914 creator A5035252455 @default.
- W3006077914 creator A5040011413 @default.
- W3006077914 creator A5044570846 @default.
- W3006077914 creator A5070844318 @default.
- W3006077914 creator A5071256788 @default.
- W3006077914 creator A5073923248 @default.
- W3006077914 creator A5083820001 @default.
- W3006077914 date "2020-06-01" @default.
- W3006077914 modified "2023-10-16" @default.
- W3006077914 title "Adenosine A2A receptor agonist (regadenoson) in human lung transplantation" @default.
- W3006077914 cites W1277628271 @default.
- W3006077914 cites W1517393168 @default.
- W3006077914 cites W1593467689 @default.
- W3006077914 cites W1680188981 @default.
- W3006077914 cites W1752304426 @default.
- W3006077914 cites W1840746127 @default.
- W3006077914 cites W1849709745 @default.
- W3006077914 cites W1977450723 @default.
- W3006077914 cites W1982729847 @default.
- W3006077914 cites W1982958883 @default.
- W3006077914 cites W1995698717 @default.
- W3006077914 cites W2014719760 @default.
- W3006077914 cites W2018364506 @default.
- W3006077914 cites W2023661512 @default.
- W3006077914 cites W2028516710 @default.
- W3006077914 cites W2032037516 @default.
- W3006077914 cites W2038302872 @default.
- W3006077914 cites W2064186539 @default.
- W3006077914 cites W2074839760 @default.
- W3006077914 cites W2082836043 @default.
- W3006077914 cites W2087851113 @default.
- W3006077914 cites W2094610766 @default.
- W3006077914 cites W2097354544 @default.
- W3006077914 cites W2099292201 @default.
- W3006077914 cites W2099402027 @default.
- W3006077914 cites W2108875876 @default.
- W3006077914 cites W2125075553 @default.
- W3006077914 cites W2129809918 @default.
- W3006077914 cites W2132649220 @default.
- W3006077914 cites W2133929886 @default.
- W3006077914 cites W2141140541 @default.
- W3006077914 cites W2146087492 @default.
- W3006077914 cites W2147216542 @default.
- W3006077914 cites W2150573258 @default.
- W3006077914 cites W2171946189 @default.
- W3006077914 cites W2280892318 @default.
- W3006077914 cites W2312270541 @default.
- W3006077914 cites W2605536236 @default.
- W3006077914 cites W2731104639 @default.
- W3006077914 cites W2749848699 @default.
- W3006077914 cites W2789542425 @default.
- W3006077914 cites W2794730840 @default.
- W3006077914 cites W2890581073 @default.
- W3006077914 cites W2912694583 @default.
- W3006077914 cites W2955926055 @default.
- W3006077914 doi "https://doi.org/10.1016/j.healun.2020.02.003" @default.
- W3006077914 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32503727" @default.
- W3006077914 hasPublicationYear "2020" @default.
- W3006077914 type Work @default.
- W3006077914 sameAs 3006077914 @default.
- W3006077914 citedByCount "15" @default.
- W3006077914 countsByYear W30060779142020 @default.
- W3006077914 countsByYear W30060779142021 @default.
- W3006077914 countsByYear W30060779142022 @default.
- W3006077914 countsByYear W30060779142023 @default.
- W3006077914 crossrefType "journal-article" @default.
- W3006077914 hasAuthorship W3006077914A5006411878 @default.
- W3006077914 hasAuthorship W3006077914A5013241838 @default.
- W3006077914 hasAuthorship W3006077914A5021842242 @default.
- W3006077914 hasAuthorship W3006077914A5025854985 @default.
- W3006077914 hasAuthorship W3006077914A5028488821 @default.
- W3006077914 hasAuthorship W3006077914A5029401500 @default.
- W3006077914 hasAuthorship W3006077914A5032571354 @default.
- W3006077914 hasAuthorship W3006077914A5035252455 @default.
- W3006077914 hasAuthorship W3006077914A5040011413 @default.
- W3006077914 hasAuthorship W3006077914A5044570846 @default.
- W3006077914 hasAuthorship W3006077914A5070844318 @default.
- W3006077914 hasAuthorship W3006077914A5071256788 @default.
- W3006077914 hasAuthorship W3006077914A5073923248 @default.
- W3006077914 hasAuthorship W3006077914A5083820001 @default.
- W3006077914 hasBestOaLocation W30060779141 @default.
- W3006077914 hasConcept C126322002 @default.
- W3006077914 hasConcept C170493617 @default.
- W3006077914 hasConcept C197934379 @default.
- W3006077914 hasConcept C2777361974 @default.
- W3006077914 hasConcept C2778213512 @default.
- W3006077914 hasConcept C2778405248 @default.
- W3006077914 hasConcept C2778938600 @default.
- W3006077914 hasConcept C2781448352 @default.